HALO logo

Halozyme Therapeutics, Inc.


HALO: Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme utilizes a strategy that focuses on developing its own proprietary products in therapeutic areas with significant unmet medical needs, with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.


Show HALO Financials

Consumer Interest
SEC Filings

Recently reported changes by institutional investors

Quarterly net insider trading by HALO's directors and management

Government lobbying spending instances

  • $20,000 Jul 16, 2023 Issue: Medicare/Medicaid
  • $30,000 Apr 19, 2020 Issue: Science/Technology Health Issues Medicare/Medicaid
  • $30,000 Jan 19, 2020 Issue: Medicare/Medicaid Science/Technology Health Issues
  • $20,000 Oct 20, 2019 Issue: Medicare/Medicaid Science/Technology Health Issues
  • $20,000 Aug 08, 2006 Issue: Health Issues Pharmacy
  • $20,000 Feb 14, 2006 Issue: Health Issues Pharmacy
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of HALO in WallStreetBets Daily Discussion


Recent insights relating to HALO

CNBC Recommendations

Recent picks made for HALO stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in HALO

Corporate Flights

Flights by private jets registered to HALO